Fermenta Biotech: Intimation of Press release regarding unaudited financial results of H1FY27
Fermenta Biotech (FERMENTA) filed a disclosure titled "Intimation of Press release regarding unaudited financial results of H1FY27". The company is valued at about ₹1,260 crore.
What happened
Fermenta Biotech (FERMENTA) filed a disclosure with the exchanges on 5 November 2026 at 01:48 PM titled "Intimation of Press release regarding unaudited financial results of H1FY27".
From the filing: "the Company regarding un audited financial results of H1 FY2 7 ."
Company snapshot
Fermenta Biotech is a small-cap company, with a market value of about ₹1,260 crore.
The stock last traded at ₹428, against a 52-week range of ₹248.9–₹582.7 (26.6% below the high).
Before this filing the shares had moved −22.6% over the month and −22.4% over three months. Average daily turnover over the last 20 sessions was about ₹5.9 crore.
Promoters held 64.09% at the end of Q2 FY27. Foreign institutions owned 0.37% and domestic institutions 0.04%.
What history shows
BCEIE's records show 4 previous results filings from the company since May 2026.
After those filings, the stock fell 4.9% on average the next trading day and was down 6.1% on average after five days (2 filings with price data).
Market-wide, 10,790 results filings with an impact score of 50 or more saw an average next-day move of −0.3%, with 42% rising.
Past reactions describe what happened before; they are not a forecast.
| Date | Filing | Next day | 5 days |
|---|---|---|---|
| 11 Aug 2026 | Unaudited Financial Results For Quarter Ended June 30, 2026. | −4.9% | −6.1% |
| 11 Aug 2026 | Board Meeting Outcome for Outcome Of Board Meeting And Unaudited… | −4.9% | −6.1% |
What to watch
- Management commentary, margins and order book or guidance in the investor presentation.
- 5 November 2026: Board meeting — Financial Results.
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.